ArticlePDF Available
Citation: Shaheen AA. Risk Factors of Keloids: A Mini Review. Austin J Dermatolog. 2017; 4(2): 1074.
Austin J Dermatolog - Volume 4 Issue 2 - 2017
ISSN : 2381-9197 | www.austinpublishinggroup.com
Shaheen. © All rights are reserved
Austin Journal of Dermatology
Open Access
Abstract
Keloid is a benign brous growth, which presents in scar tissue of
predisposed individuals. It is a result of irregular wound healing, but the exact
mechanism is unknown. However, it is possible that several factors such as
age of onset, sex, cause of scarring, blood groups, anatomical site, presence
of family history and number of injured sites (multiple/single) have an important
role in keloid formation and consequentially in predicting keloid’s behavior in
response to treatment and prognosis. In this mini review, we have demonstrated
these risk factors of keloids in detail.
Keywords: Keloids; Risk factors; Family history; Melanin; Blood groups;
Cause of scarring; Anatomical site; Multiple sites; Sex; Age of onset
Introduction
Keloid is a benign brous growth, presents in scar tissue of
predisposed individuals, extends beyond the borders of the original
wound, doesn’t usually regress spontaneously, and tends to recur
aer excision. It is a result of irregular wound healing following skin
insults (trauma, inammation, surgery, burns…etc.), but sometimes
occur spontaneously. Most keloids develop within 3 months of the
injury, but some may occur up to 1 year aer skin insults [1]. First
described in the Edward Smith papyrus in Egypt around 1700 BC [2].
Keloids appear as rm, mildly tender, boss elated tumors with a shiny
surface. In the Caucasian patient, keloids tend to be erythematous
and telangiectatic; they are oen hyperpigmented in darker-skinned
individuals. Keloids are oen pruritic and painful, in addition to
signicant eects of patient’s quality of life, both physically and
psychologically, especially in excessive scarring [3,4].
e main dierential diagnosis of keloid is hypertrophic scar,
also called pseudokeloid. Dierential diagnosis is important, since
treatment procedures dier between these two types of scar disorders.
Hypertrophic scars, which dened as raised scars that remained within
the boundaries of the original lesion, oen regressing spontaneously
aer the initial injury and rarely recurring aer surgical excision.
In contrast, a keloid scar is dened as a dermal lesion that spreads
beyond the margin of the original wound, continues to grow over
time, does not regress spontaneously and commonly recurring aer
excision [1].
e process by which keloid develops is poorly understood, but
it is known to be induced by skin insults in predisposed individuals.
ere are several theories of keloid etiology, most of them are related
to broblast dysfunction. Keloid broblasts, when compared with
broblasts isolated from a normal wound, have excessive deposition
of extracellular matrix components, especially collagen, bronectin,
elastin, proteoglycans. In addition, these cells have lower rates of
apoptosis [2,5].
Risk Factors of Keloids (Epidemiology and
Etiology)
Several factors play a signicant role in keloids formation. e
Mini Review
Risk Factors of Keloids: A Mini Review
Shaheen AA*
Department of Dermatology, Tishreen University, Syria
*Corresponding author: Abeer Ali Shaheen,
Department of dermatology, Tishreen University,
Lattakia, Syria
Received: May 17, 2017; Accepted: June 12, 2017;
Published: June 19, 2017
genetic predisposition is the most important factor; other factors are
blood groups, melanin, the anatomical site, the type of skin injury, the
age of onset, and sex [1].
Genetic predisposition
ere is a clear genetic component given the correlation with
family history, which supported by the following phenomena: (a)
some patients with keloids report a positive family history. 19.3%
of Syrian patients had a family history [1], 50% of Afro Caribbean
patients [6], and 36.4% of Nigerian patients [7]. (b) High occurrence
in identical twins [6,8,9]. (c) ere are higher predisposition in Blacks,
Hispanics and Asians, less frequently in Caucasians [6]. (d) Increased
incidence of keloids in patients with some genetic syndromes like
Turner syndrome, Opitz-Kaveggia syndrome, Rubinstein Taybi
syndrome and Ehlers Danlos syndrome [10].
Proposed inheritance patterns include autosomal recessive,
autosomal dominant with incomplete penetrance, and variable
expression [8,11]. Several genes are considered responsible for keloid
disease, but no single gene mutation has thus far been found to be
responsible [12].
(a) Genome wide association study in Japanese population
has shown that four SNP (Single Nucleotide Polymorphism) loci
in three chromosomal regions (1q41, 3q22.3-23 and 15q21.3)
exhibit signicant associations with keloids [13]. (b) Marneros
and colleagues studied two families with an autosomal dominant
inheritance pattern of keloids (Japanese family and African American
one). ey identied linkage to chromosome 2q23 (maximal two-
point LOD score of 3.01) for the Japanese family. e African-
American family showed evidence for a keloid susceptibility locus
on chromosome 7p11 (maximal two-point LOD score of 3.16) [14].
(c) Brown and colleagues found a genetic association between HLA-
DRB1*15 statuses and the risk of developing keloid scarring in white
individuals [15]. (d) Also, carriers of HLA-DQA1*0104, DQB1*0501
and DQB1*0503 have been reported to be have an increased risk of
developing keloid scarring [3].
ere is importance of the cause and anatomical site in the added
heredity of keloids. 76% of patients with family history have keloids
located in the same anatomical sites of the relative, and 66% of them
Austin J Dermatolog 4(2): id1074 (2017) - Page - 02
Shaheen AA Austin Publishing Group
Submit your Manuscript | www.austinpublishinggroup.com
have keloids caused by the same cause [1]. Also, there is predisposition
to heredity spontaneous keloids, which usually appears in the second
decade, presternal and shoulder keloids [1]. In addition, family
history is strongly associated with the formation of keloid scars in
multiple sites as opposed to a single anatomical site [6].
Blood groups
People with blood group A have high probability to develop
keloids compared with other blood groups, that may be partly
explained by the association between the eect of red cell antigens
A (which present on the membrane surface of red blood cells and
certain epithelial cells) and other factors in these patients [1,9]. A
study by Shaheen [1] revealed association between spontaneous
keloids and blood group A (p = 0.01), which conrms the eect of red
cell antigens A in development of keloids. (is nding has not been
previously reported).
Melanin
ere is a relationship between keloid formation and skin color,
as supported by the following phenomena: (a) Colored skin people
such as the Negroid and Mongoloid races have a greater tendency to
suer from keloid compared to the Whites (the Caucasian race). e
comparative ratio between Blacks and Whites who suer from keloid
varies extensively, ranging from 5 up to 18.7 to one. On the other
side, evidently keloid is not found among albino which is a condition
where there is absent or minimal melanin pigment [5,6,16-18]. (b)
e incidence of pathological scarring varies across dierent parts
of the body even in the same individual; for example, fewer keloids
develop in the palm and thenar eminence, where melanocytes are
less common [17,19]. (c) Adolescents and pregnant women, who are
subjected to increased hormone secretion and skin pigmentation, are
more susceptible to developing keloids [17]. Based on these facts, it
becomes apparent that the incidence of keloid is strongly related to
skin color. Melanin is the most important pigment which determines
variations in skin color of the various races in the world [2,20].
e relationship between melanin and keloid formation have been
assumed by several theories: (a) During wound healing, melanocytes
from the stratum basal contact or interact with broblasts from the
dermal layers aer the basal membrane is damaged, which in turn
facilitates broblast proliferation and the secretion and deposition of
collagen [2]. (b) High levels of melanin cause decreasing of histologic
PH, which inhibit collagenase, that disrupts collagen degradation
process [20].
Causes of keloids (Type of skin injury)
Keloids may develop following any skin injury like non-
inammatory conditions such as burn, trauma, surgery, piercings,
or inammatory skin conditions such as acne vulgaris, folliculitis,
varicella infection, or vaccinations (particularly BCG vaccination)
[3,19], but not all such insults lead to a keloid scar even in the
susceptible individuals [6]. is means all types of skin injuries could
cause keloids, but each patient is aected by specic type of injuries.
at indicate to the role of type of skin injury in keloid formation,
which supported by the higher prevalence of single keloid more than
multiple keloids, although the patient is exposed to other injuries that
may cause keloid. On other hand, there are very few patients have
keloids caused by two dierent causes [21].
e most common cause of keloid diers according to conditions
of study’s society. Syrian [1] and Iranian studies [22] found that
keloids could follow any form of skin injury, but burns were the most
common. Bayat [6] found that laceration was the most common cause
in Afro Caribbean patients. However, the occurrence of a keloid or
hypertrophic scar following BCG vaccination is not uncommon
and is likely more to the inammatory nature of the injection
response rather than the size of the wound [19]. Causes have almost
coordinated distribution in males and females, but males have higher
predisposition to develop acne keloids compared to female, because
only males have acne keloidalis nuchae, and the severity of acne is
higher in them [1].
Spontaneous keloid is a rare condition, and it is controversial
whether it is in fact spontaneous. e scar tissue may form aer an
insignicant inammatory reaction or injury which the patient has
no recollection of. Syrian study [1] found 13.4% of spontaneous
keloids, which was similar to Togo study 13.13% [21], but lesser
than an Iraqi one 34% [23]. As we said before, some patients have
hereditary of spontaneous keloids, while others have association with
blood group A [1]. ere is conrmed evidence of the association
between spontaneous keloid formation and dierent diseases such
as Dubowitz syndrome, Rubenstein-Taybi syndrome, and Noonan
syndrome. In addition, Spontaneous keloid has been reported in
siblings and in people with allergic diseases [24].
ere are very few patients have keloids caused by two dierent
causes [1]. ey are only 2.32% of patients in Syrian study [1], 83.3% of
them had surgical keloids, so we have to be careful when performing
surgery for a patient who had a previous keloid. On other hand, this
percentage is higher in dark skin patients 15.9% [21], maybe because
developing keloid is more common in Blacks than in Whites.
Keloids could follow any skin insults, but there is association
between anatomical sites and specic injuries. Shaheen [1] found
that burn was the most common cause of keloid formation in
uncovered sites (face (35%), neck (50%), upper limbs (44.29%, lower
limbs (66.66%), and chest wall (27.59%)),) and less aected sites
(lower back (37.5%), button (50%), genitalia (50%), palm and sole
(66.66%)), which disagree partly with the Japanese study, found that
trauma was the most common cause of extremities keloids [25]. Ear
piercing is the most common cause for earlobe keloid [1,6,25]. Acne
is the most common cause for scalp keloids [1,6]. More than quarter
of shoulder keloids were caused by acne [1,25]. e Syrian study [1]
found that Most sternum keloids were spontaneous (35.82%), or
followed surgery (37,13%), while most sternum keloids were caused
by trauma in Jamaican study [6], or acne in Japanese study [25]. At
last, abdominal keloids followed by surgery in several study, more
than half of abdominal keloids followed surgery in the Syrian study
[1], while all abdominal keloids followed surgery in the Japanese
study [25].
Anatomical site
Several studies indicated to the role of anatomical site in keloid
formation, which supported by the following phenomena: (a)
Genetically susceptible individuals form keloids aer wounding
but not at every body site [6]. (b) Generally keloids tend to occur
on highly mobile sites with high tension such as shoulders, neck,
and presternum [26,27]. (c) ere are familial patterns of keloid
distribution [11].
Austin J Dermatolog 4(2): id1074 (2017) - Page - 03
Shaheen AA Austin Publishing Group
Submit your Manuscript | www.austinpublishinggroup.com
Anterior chest, shoulders, earlobes, upper arms and cheeks have
a higher predilection for keloid formation. Eyelids, cornea, palms,
mucous membranes, genitalia and soles are generally less aected
[3]. e most common anatomical site for developing keloids diers
according to race, traditions and conditions of study’s society.
Shaheen [1] indicated that upper limb 20% followed by sternum
19.17% were the most common sites for developing keloids in Syrian
patients. Similarly, Abas Mouhari Toure [21] noted that sternum
28.95%, upper limb 15.8% and head 16.7% were the most common
sites in dark skin patients. Conversely, ear 23% was the most common
one in Bayat’s study [6]. On other hand, most of studies agree that
genitalia, buttock, palm and sole are the rarest sites for developing
keloids [1,6,7,21].
Few studies discussed the development of keloids in single versus
multiple anatomical sites and its correlation with patient’s clinical
feature and prognosis [1,6]. Shaheen [1] found that 19.3% of patients
had keloids in multiple anatomical sites, where upper limb was the
most common site for developing keloids in them 46%, and burn was
the most common cause 38.2%. Bayat [6] demonstrated that 42.2% of
patients had keloids in multiple anatomical sites, where earlobe was
the most common site in multiple 24% sites, and ear piercing was the
most common cause. Although all causes tend to develop keloids in
multiple sites, only burn and acne have association with developing
keloid in multiple sites in Syrian patients (p = 0.029) (p = 0.0002)
respectively, which means there is high probability to develop acne or
burn keloids in another anatomical site in a patient who had a previous
acne or burn keloid respectively, because both acne and burn could
aect multiple sites more than other causes, which is more located
[1]. Female sex, younger age at presentation and the presence of a
positive family history are associated with the development of keloid
scars in multiple anatomical sites in Afro Caribbean individuals [6].
A previous study reported that 1.93% of patients have keloids caused
by two dierent causes, and distributed on multiple anatomical sites.
is may be indicate that very few people have a high predisposition
to develop keloids, but this nding needs more research.
Keloids could develop at any anatomical sites, but there is
association between type of skin injury and specic anatomical sites.
Syrian study [1] found that 80% of spontaneous keloids were located
on sternum and shoulders, this agree partly with a previous study,
which demonstrated that sternum was the most common site for
spontaneous keloids [28]. Also, 45% of burn keloids were located on
extremities (lower and upper) in that study [1], while a Japanese study
found that all burn keloids were located on chest wall and lower limbs
[25]. About 40% of sharp wound keloids were located on upper limbs,
and 50% of surgical keloids were located on sternum and abdominal
wall [1,25]. Sternum and shoulder are the most common site for acne
keloids. Syrian study [1] found that about half of acne keloids were
located in these sites, while most acne keloids were located in these
sites in the Japanese study [25]. 37% of trauma keloids were located
on face and upper limb in Syrian patients [1], which agree partly with
the Japanese study [25], which found that most trauma keloids were
located on extremities (upper and lower).
Epidemiologic variances (sex and age)
Incidence of keloids is usually equal in females and males
[9,21,23,29], but sometime there is higher incidence in female [6,29]
(it could be related to the higher rate of earlobe piercing in females),
or in male (it could be related to acne keloidalis nuchae, especially
in Blacks) [7]. In general, both sexes develop keloids in the same
anatomical sites, and followed to the same injuries, but sometimes
there is preference for one gender to develop keloids in specic site,
following specic cause, at specic age. Males who are older than forty
could develop keloids more than females in the same age (as we will
discuss later). Also, males have higher predisposition to develop acne
and scalp keloids compared to female, because only males have acne
keloidalis nuchae, also, the severity of acne is higher in them [1]. As we
said before, Female sex is associated with the development of keloid
scars in multiple anatomical sites in Afro Caribbean individuals [6].
Although keloids could occur at any age, they are rare in rst
decade, because people in this decade are not stimulated by sexual
hormones (higher incidence of keloid formation during puberty)
[1,3,16]. Most likely to occur in second and third decades and tend
to decrease in older [1,6,9,17], which supported by the following
phenomena: (a) younger people may have a higher frequency of
trauma, their skin is more elastic than the skin of elderly people [29],
(b) they have higher level of sexual hormone than older people (Keloid
growth may also be stimulated by various hormones, as indicated
by some studies in which results have suggested a higher incidence
of keloid formation during puberty and pregnancy, with a decrease
in size aer menopause, that related to localized hyper androgen
metabolism which may play a causal or at least contributory role
in the pathogenesis of keloids, or elevated androgen receptor levels
exist in clinical active keloid tissue [30,31]) [1,3,16,19]. Also, younger
age is associated with the development of keloid scars in multiple
anatomical sites [6]. Each decade has preference to develop keloids
in specic site, following specic cause. Burn is the most common
cause for developing keloids in rst decade compared with other
decades, especially on upper and lower limbs. is is a logical result,
because most of burn accidents exist in younger children especially
on extremities [1]. Occurrence of acne keloids is higher in second
decade compared with other decades, because the peak in prevalence
and severity of acne occurs in second decade. High frequency of
sharp wound accidences and earlobe piercing in second decade
explain the higher incidence of these keloids in this decade [1]. Also,
development of scalp keloids is higher in second decade compared
with other decades, because most cases of acne keloidalis nuchae
occur in persons aged 14-25 years (most cases of scalp keloids are
caused by keloidalis nuchae) [1]. ere is absence of acne keloids in
fourth decade, because frequency of acne extremely decrease in this
decade [1]. At last, development of surgical keloids is higher in h,
sixth and seventh decades compared with other decades, especially on
sternum. ese results reect an increase of open heart surgeries in
older people, especially for males who are older than forty compared
to females in the same age [1].
Note: e above risk factors are unmodiable factors, but there
are modiable factors like delayed healing [32], and hypertension
[33].
Delayed healing
is usually occurs as a result of wound infection or if wound
edges are not apposed. is will lead to healing by second intention
as the defect lls gradually with granulation tissue and restoration of
epidermal continuity may take a considerable time. Healing by second
Austin J Dermatolog 4(2): id1074 (2017) - Page - 04
Shaheen AA Austin Publishing Group
Submit your Manuscript | www.austinpublishinggroup.com
intention usually results in prolonged healing, excessive brosis and
an ugly puckered scar as opposed to healing by rst intention which
occurs following the meticulous apposition of the edges of clean
incised skin. is leaves a narrow epidermal defect which can be
bridged easily resulting in a ne hairline scar. us healing by second
intention is more likely to develop keloids especially if healing time is
greater than three weeks [32].
Hypertension
ere is relationship between hypertension and development of
severe keloids. Blood pressure associated significantly and positively
with both keloid size and number (both p <0.0001). is association
may reflect the fact that hypertension damages blood vessels, thereby
increasing inflammation in local tissue [33].
Treatment
No single therapeutic modality is best for all keloids. e location,
size, and depth of the lesion; the age of the patient; and the past
response to treatment determine the type of therapy used. ere are
several options in keloid treatment [34].
Standard treatments
ese include occlusive dressings, compression therapy, and
intralesional corticosteroid injections. Occlusive dressings include
silicone gel sheets and dressings, nonsilicone occlusive sheets, and
cordran tape. ese measures have been used with varied success.
Antikeloidal eects appear to result from a combination of occlusion
and hydration, rather than from an eect of the silicone. Compression
therapy involves pressure, which has long been known to have
thinning eects on skin. Reduction in the cohesiveness of collagen
bers in pressure treated hypertrophic scars has been demonstrated
by electron microscopy. Cellular mechanoreceptors may have an
important role of compression therapy. Mechanoreceptors induce
apoptosis and are involved in the integrity of the extracellular matrix.
Corticosteroids, specically intralesional corticosteroid injections,
have been the mainstay of treatment. Corticosteroids reduce excessive
scarring by reducing collagen synthesis, and reducing production of
inammatory mediators and broblast proliferation during wound
healing. e most commonly used corticosteroid is Triamcinolone
Acetonide (TAC) in concentrations of 10-40mg/mL administered
intralesionally at four to six week intervals. Intralesional steroid
therapy as a single modality and as an adjunct to excision has been
shown to be ecacious in various studies.
Cryotherapy
Cryosurgical media like liquid nitrogen aects the
microvasculature and causes cell damage via intracellular crystals,
leading to tissue anoxia. Generally, 1, 2, or 3 freeze-thaw cycles lasting
10-30 seconds each are used for the desired eect. Treatment may
need to be repeated every 20-30 days.
Excision
Decreased recurrence rates have been reported with excision
in combination with other postoperative modalities, such as
radiotherapy, injected IFN, or corticosteroid therapy.
Radiotherapy
Radiation destroys broblasts in the wound, prevents
neovascularization, which ultimately leads to a decreased production
of collagen.
Laser therapy
Ablative lasers (carbon dioxide 10,600nm, Erbium: Yttrium
Aluminum Garnet Laser Er: YAG 1064nm, and Argon 488-nm
laser). Nonablative lasers (Pulsed-dye laser 585nm): it provides
photothermolysis, resulting in microvascular thrombosis. e PDL
remains the laser treatment of choice for keloids hypertrophic scars.
Intralesional\topical apply of following drugs: IFN injections,
5-Fluorouracil, Doxorubicin (Adriamycin), Bleomycin, Verapamil,
Retinoic acid, Imiquimod 5% cream, Tamoxifen, Tacrolimus, and
Botulinum Toxin A.
Other promising therapies
e antiangiogenic factors, including the Vascular Endothelial
Growth Factor (VEGF) inhibitors (e.g. Bevacizumab). Phototherapy
(Photodynamic erapy - PDT), UVA-1 therapy, narrow band UVB
therapy. Tumor Necrosis Factor (TNF) alpha inhibitor (etanercept).
Recombinant Human Interleukin (rhIL-10) which are directed at
decreasing collagen synthesis [34].
Conclusion
It is possible that several factors have an important role in keloid
formation and consequentially in predicting a keloid’s behavior in
response to treatment and prognosis. e genetic predisposition is
the most important factor, but no single gene mutation has thus far
been found to be responsible. People with blood group A have high
probability to develop keloids compared with other blood groups.
ere is a relationship between keloid formation and skin color,
Blacks have a greater tendency to suer from keloid compared to the
Whites. All types of skin injuries could cause keloids, but each patient
is aected by specic type of injuries, which indicate to the role of type
of skin injury in keloid formation. Genetically susceptible individuals
form keloids aer wounding but not at every body site, which indicate
to the role of anatomical site in keloid formation. ere is importance
of the cause and anatomical site in the heredity of keloids. Burn, acne,
female sex, younger age at presentation and the presence of a positive
family history are associated with the development of keloid scars
in multiple anatomical sites. Males who are older than forty could
develop keloids more than females in the same age. Also, males have
higher predisposition to develop acne and scalp keloids compared to
female. Although keloids could occur at any age, they are rare in rst
decade, most likely to occur in second and third decades and tend to
decrease in older. ere are modiable factors like delayed healing,
and hypertension.
References
1. Shaheen A, Khaddamand J, Kesh F. Risk factors of keloids in Syrians. BMC
Dermatology. 2016; 16: 13.
2. Gao FL, Jin R, Lu Z, Zhang YG. The contribution of melanocytes to
pathological scar formation during wound healing. Int J Clin Exp Med. 2013;
6: 609-613.
3. Gauglitz GG, Korting HC, Pavicic T, Ruzicka T, Jeschke MG. Hypertrophic
Scarring and Keloids: Pathomechanisms and Current and Emerging
Treatment Strategies. Mol Med. 2011; 17: 113-125.
4. Chuma J, Chike O, Cole PD, Brissett AE. Keloids: Pathogenesis, Clinical
Features, and Management. Semin Plast Surg. 2009; 23: 178-184.
5. Goyal S, Saini I, Goyal S. Familial Keloid in Indian Scenario: Case Report and
Austin J Dermatolog 4(2): id1074 (2017) - Page - 05
Shaheen AA Austin Publishing Group
Submit your Manuscript | www.austinpublishinggroup.com
Review of Literature. Open Access Library Journal. 2015; 2: e1578.
6. Bayat A, Arscott G, Ollier WE, McGrouther DA, Ferguson MWJ. Keloid
disease: clinical relevance of single versus multiple site scare. Br J Plast
Surg. 2005; 58: 28-37.
7. Olaitan PB, Olabanji JK, Oladele AO, Oseni GA. Symptomatology of keloids
in Africans. Sierra Leone Journal of Biomedical Research. 2013; 5: 29-33.
8. Sukari HA, Emami Z, Salahshourifar I, Kannan TP. Keloid scarring:
understanding the genetic basis, advances, and prospects. Archives of
plastic surgery. 2012; 39: 184-189.
9. Ramakrishnan KM, Thomas KP, Sundararajan CR. Study of 1,000 patients
with keloids in south India. Plast Reconstr Surg. 1974; 53: 276-280.
10. Sun LM, Wang KH, Lee YC. Keloid incidence in Asian people and its
comorbidity with other brosis-related diseases: a nationwide population-
based study. Arch Dermatol Res. 2014; 306: 803-808.
11. Clark JA, Turner ML, Howard L, Stanescu H, Kleta R, Kopp JB. Description
of familial keloids in ve pedigrees: Evidence for autosomal dominant
inheritance and phenotypic heterogeneity. BMC Dermatology. 2009; 9: 1-9.
12. Shih B, Bayat A. Genetics of keloid scarring. Archives of Dermatological
Research. 2010; 302: 319-339.
13. Nakashima M, Chung S, Takahashi A, Kamatani N, Kawaguchi T, Tsunoda
T, et al. A genome-wide association study identies four susceptibility loci for
keloid in the Japanese population. Nat Genet. 2010; 42: 768-771.
14. Marneros AG, Norris J E, Watanabe S, Reichenberger E, Olsen BR. Genome
scans provide evidence for keloid susceptibility loci on chromosomes 2q23
and 7p11. J Invest Dermatol. 2004; 122: 1126-1132.
15. Brown JJ, Ollier WE, Thomson W, Bayat A. Positive association of HLA-
DRB1*15 with keloid disease in Caucasians. Int J Immunogenet. 2008; 35:
303-307.
16. Henriquez CB, Costa F. Resident’s Thesis Systematization of treatment
of keloid at the Plastic Surgery Unit of the 38th Inrmary of Santa Casa de
Misericórdia do Rio de Janeiro. Plastic Surgery Bulletin. 2014.
17. Gao FL, Jin R, Zhang L, Zhang YG. The contribution of melanocytes to
pathological scar formation during wound healing. International Journal of
Clinical and Experimental Medicine. 2013; 6: 609-613.
18. Wolfram D, Tzankov A, Pülzl P, Piza-Katzer H. Hypertrophic scars and
keloids--a review of their pathophysiology, risk factors, and therapeutic
management. Dermatol Surg. 2009; 35: 171-181.
19. Robles DT, Moore E, Draznin M, Berg D. Keloids: Pathophysiology and
management. Dermatology Online Journal. 2007; 13: 9.
20. Perdanakusuma DS. The effect of melanin concentration on collagen
accumulation in keloid. Folia Medica Indonesiana. 2006; 42: 218- 227.
21. Toure AM, Saka B,’eKombat’e K, Akakpo S, Egbohou P, Walla KT, et al.
Is There an Association between Keloids and Blood Groups? International
Scholarly Research Network ISRN Dermatology. 2012; 4.
22. Jannati P, Aref S, Jannati AA, Jannati F, Moravvej H. Comparison of
Therapeutic Response of Keloids to Cryotherapy Plus Intralesional
Triamcinolone Acetonide or Verapamil Hydrochloride. Journal of Skin and
Stem Cell. 2015; 2: e29284.
23. Sharquie KE, Al-Dhalimi MA. Keloid in Iraqi Patients: A Clinicohistopathologic
Study. Dermatol Surg. 2003; 29: 847-851.
24. Monarca C, Maruccia M, Palumbo F, Parisi P, Scuderi N. A rare case of
Postauricular Spontaneous Keloid in an Elderly Patient. In Vivo. 2012; 26:
173-175.
25. Ogawa R, Mitsuhashi K, Hyakusoku H, Miyashita T. Postoperative Electron-
Beam Irradiation Therapy for Keloids and Hypertrophic Scars: Retrospective
Study of 147 Cases Followed for More Than 18 Months. Plast. Reconstr.
Surg. 2003; 111: 547-553.
26. Naylor MC, Brissett AE. Current concepts in the etiology and treatment of
keloids. Facial Plastic Surgery. 2012; 28: 504-512.
27. Ogawa R, Okai K, Tokumura F, Mori K, Ohmori Y, Huang C, et al. The
relationship between skin stretching/contraction and pathologic scarring: The
important role of mechanical forces in keloid generation. The International
Journal of Tissue repair and Regeneration. 2012; 20: 149-157.
28. Kelly AP. Update on the Management of Keloids. Seminars in Cutaneous
Medicine and Surgery. 2009; 28: 71-76.
29. Philandrianos C, Kerfant N, Jaloux C, Martinet L, Bertrand B, Casanova
D. Keloid scars (part I): Clinical presentation, epidemiology, histology and
pathogenesis. Annales de chirurgieplastique et esthtique. 2016; 61: 128-
135.
30. Ford LC, King DF, Lagasse LD, Newcomer V. Increased androgen binding
in keloids: a preliminary communication. J Dermatol Surg Oncol. 1983; 9:
545-547.
31. Schierle HP, Scholz D, Lemperle G. Elevated levels of testosterone receptors
in keloid tissue: an experimental investigation. Plast Reconstr Surg. 1997;
100: 390-395.
32. Weledji EP, Ngwane S. The Management of Keloids and Hypertrophic Scars.
Darlington and County Durham Medical Journal. 2012; 6: 39-45.
33. Ogawa R. Keloid and Hypertrophic Scars Are the Result of Chronic
Inammation in the Reticular Dermis. International Journal of Molecular
Sciences. 2017; 18: 606.
34. Berman B, Elston DM. Keloid and Hypertrophic Scar Clinical Presentation.
Medscape. 2016.
Citation: Shaheen AA. Risk Factors of Keloids: A Mini Review. Austin J Dermatolog. 2017; 4(2): 1074.
Austin J Dermatolog - Volume 4 Issue 2 - 2017
ISSN : 2381-9197 | www.austinpublishinggroup.com
Shaheen. © All rights are reserved
... The common sites are the chest, earlobes, jaws, upper arm, and breast. 1,3,7 The identified risk factors for keloid scars include race, family history, increased wound tension, blood group A, young age, previous history of keloid in the same individual, and healing by second intention. [1][2][3]7 When these lesions develop, they can be a source of emotional distress. ...
... 1,3,7 The identified risk factors for keloid scars include race, family history, increased wound tension, blood group A, young age, previous history of keloid in the same individual, and healing by second intention. [1][2][3]7 When these lesions develop, they can be a source of emotional distress. The common physical symptoms of keloid are pain, pruritus, and purulent discharge. ...
... The common physical symptoms of keloid are pain, pruritus, and purulent discharge. 4,7 There is a paucity of literature on the epidemiology and presentation of keloid in southern Nigeria. This study was therefore carried out to determine the basic epidemiology and pattern of presentation of keloid in a tertiary hospital southern Nigeria. ...
... The ratio of keloids between dark-and light-skinned people is between 5 and 18.7. Meanwhile, no case has been reported in albinos [3], [5], [6]. ...
... The same was found by Udo-Affah, who found the highest frequency in people who are 22-29 years old [18]. However, an increase in elastic skin conditions and high hormonal activity can also affect this condition (5). Based on UV exposure, it was discovered that with active and productive such that most of their activities are conducted outside, thus the risk of getting UV exposure was high, and consequently increasing keloid [19], [20]. ...
... Furthermore, the longest period for the disease was found to be 1-3 years, and some others were discovered to have it more than 3 years after the injury. It usually appears from months to years after trauma [5], [22]. Based on location, it is mostly found in the head and around the neck. ...
Article
Full-text available
BACKGROUND: Keloid is a form of wound healing that results from fibrous tissue activity. It can develop beyond the boundaries of the original wound, extends into the dermis layer, and disrupting the appearance. Previously, no studies have revealed a correlation between melanin pigment and keloid. AIM: This research aimed to describe the correlation between melanin concentration and collagen deposition in keloid tissue. MATERIALS AND METHODS: A prospective study conducted through the application of a cross-sectional analytic survey method. The color of the skin was measured using a chromameter, and a histopathologic examination was performed on the skin surrounding the keloid, as well as the keloid tissue. Data were analyzed using a t-test, correlation, and linear regression statistics. RESULTS: The results showed a significant difference between melanin concentration and collagen deposition in the skin surrounding the keloid tissue. No significant difference was observed between melanin concentration in the surrounding skin of keloid and those in the keloid tissue, as well as collagen deposition. Meanwhile, the melanin concentration in the surrounding skin of keloid and keloid tissue had a significant relationship with fibrocytes number. CONCLUSION: There is a significant correlation between melanin concentrations and collagen density in the keloid tissue.
... First-line therapies include silicone sheeting, compressive dressings, and intralesional corticosteroid injections. 4 While other non-invasive methods such as ultrasound, laser, and cryotherapy exist, these approaches have highly individualized responses to treatment. Surgical excision is considered the definitive treatment for keloids, though it carries the risk of new and worsening keloid formation. ...
... Newer therapies aim to interfere with the pathophysiologic progression of keloids. 4,5 Monoclonal antibodies targeting signaling pathways and angiogenesis can help reduce these recurrence rates. ...
Article
Full-text available
The psychosocial well-being of adolescents, leading to anxiety, depression, and social withdrawal during a critical period of identity formation. Current literature highlights these challenges but lacks comprehensive management strategies within dermatological practice. This review identifies the need for integrated care models that combine clinical treatment with mental health support, including routine psychosocial screening, immediate counseling referrals, and adolescent-specific education programs on keloid management and emotional coping. Training dermatologists to recognize psychological distress and adopt compassionate communication is essential. Collaborative research should focus on evaluating these integrative care models and developing evidence-based guidelines. By pioneering these comprehensive strategies, dermatology practices can improve physical outcomes and significantly enhance the quality of life for adolescents with keloids, addressing both the physical and psychological scars. Future research should prioritize the longitudinal impact of these interventions on mental health and treatment adherence, establishing a new standard of care that fully supports adolescent keloid patients. By implementing these comprehensive strategies, dermatology practices can enhance physical outcomes and significantly improve the quality of life for adolescents with keloids, addressing both the physical and psychological impacts in the management of keloids in this vulnerable population.
... Keloids occur more often at the age of 20-30 years because there is higher stimulation of sexual hormones, while in older persons, sexual hormones tend to decrease. 19 In addition, excessive sebaceous secretion and elastic skin conditions in adolescents make them prone to keloid formation. 20 These findings highlight the importance of more optimal keloid prevention and management strategies for younger individuals undergoing surgical procedures. ...
Article
Full-text available
Highlights: Previous keloid surgery mostly caused keloid recurrence. The most common symptom that accompanies keloids in surgical wounds was itching. Surgery and combination therapy were the most used therapy. Abstract: Introduction: Keloid is an abnormal scar resulting from disruptions in the wound healing process. Clinically, keloids extend beyond the original wound margins and progressively enlarge into dense, firm nodules. They can develop following various forms of trauma, including surgical procedures. Several factors contribute to keloid formation in surgical wounds, such as age, gender, genetics, skin color, hormones, incision location, wound tension, and delayed healing. Methods: This retrospective descriptive study analyzes medical records of patients diagnosed with keloids due to surgical wounds at the Department of Plastic and Reconstructive Surgery, Dr. Soetomo General Academic Hospital, Surabaya, between 2019 and 2022. Results: Among 58 keloid patients, 23 developed keloids following surgery. The most common risk factor was a history of previous keloid surgery. The majority of patients were female, aged 17–25 years, students, and had no family history of keloids. The most frequent keloid location was the chest, with an onset of ≥1 year, a size of <20 cm², and associated itching. Surgical excision and combination therapy were the most commonly used treatment approaches. Conclusion: Previous keloid surgery is the primary risk factor for developing keloids in surgical wounds. Surgery and combination therapy remain the most frequently employed treatment strategies.
... Transport upward to the stratum corneum, causing darkening of the skin [47]. The incidence of KD in dark-skinned people is much higher than that in light-skinned people [48]. Our study reveals the role and mechanism of the abnormal axis of melanin synthesis, iron metabolism, and ferroptosis in KD. ...
Article
Full-text available
Background: Keloid is a typical skin fibrotic disease with unclear mechanisms and limited therapeutic options. Fibroblast-induced fibrogenesis is a crucial cause of KD. However, the types of cells involved in fibroblast fibrogenesis in KD and the specific mechanisms are unclear. This study aimed to investigate the role of melanocyte-secreted melanin in promoting fibroblast fibrogenesis and its mechanism and to evaluate the potential therapeutic effect of intervening melanin in treating keloid. Methods: The activity of pigmentation-related pathways in KD melanocytes was examined using single-cell RNA-sequence (scRNA-seq) analysis. Masson-Fontana staining or isolated melanin quantification detected the melanin levels and distribution in the skin and cells. Collagen deposition, wounding healing, and proliferation analysis were employed to integratively assess fibroblast fibrogenesis. After melanin treatment, bulk-seq identified fibroblasts' differentially expressed genes (DEGs). The iron levels were detected by Perl's staining or isolated iron quantification. Cell viability, LipidROS, and malondialdehyde assay accessed the ferroptosis levels. The therapeutic potential of ML329 was evaluated in keloid-bearing mice. Results: We found the enriched skin pigmentation-related pathways in the melanocytes of keloid by single-cell RNA-sequence (scRNA-seq) analysis. We further validated increased melanin levels in keloid patients. Additionally, melanin positively correlated with the Keloid Area and Severity Index in keloid. Furthermore, melanocyte-secreted melanin significantly promoted fibroblast proliferation, migration, and collagen synthesis. Mechanically, melanin increased basal cell permeability and inflammation to facilitate its transfer to the dermis, where it further activated fibroblasts by evoking iron overload and ferroptosis resistance. Consistently, iron overload and ferroptosis resistance were validated in primary fibroblasts and skin tissues of keloid patients. Inhibition of iron overload and ferroptosis resistance effectively diminish melanin-induced fibrogenesis. Interestingly, melanin induced iron overload and ferroptosis resistance in melanocytes in an autocrine manner and further stimulated keratinocytes to take up melanin to deepen skin color by upregulating the F2R-like trypsin receptor 1 (F2RL1). In vivo, the delivery of ML329, a microphthalmia-associated transcription factor (MITF) inhibitor, could suppress melanogenesis and alleviate keloid in human keloid-bearing nude mice. Meanwhile, ML329 decreased the iron content and restored the sensitivities of ferroptosis. Conclusion: Collectively, melanin-lowing strategies may appear as a potential new therapeutic target for keloid.
... Transport upward to the stratum corneum, causing darkening of the skin [39]. The incidence of KD in dark-skinned people is much higher than that in lightskinned people [40]. Our study reveals the role and mechanism of the abnormal axis of melanin synthesis, iron metabolism, and ferroptosis in KD. ...
Preprint
Full-text available
Keloid is a typical skin fibrotic disease with unclear mechanisms and limited therapeutic options. In this study, we found the enriched skin pigmentation-related pathways in the melanocytes of keloid by single-cell RNA-sequence (scRNA-seq) analysis. We further validated increased melanin levels in keloid patients. Additionally, melanin positively correlated with the Keloid Area and Severity Index in keloid. Furthermore, melanocyte-secreted melanin significantly promoted fibroblast proliferation, migration, and collagen synthesis. Mechanically, melanin increased basal cell permeability and inflammation to facilitate its transfer to the dermis, where it further activated fibroblasts by evoking iron overload and ferroptosis resistance. Consistently, iron overload and ferroptosis resistance were validated in primary fibroblasts and skin tissues of keloid patients. Inhibition of iron overload and ferroptosis resistance effectively diminish melanin-induced fibrogenesis. Interestingly, melanin induced iron overload and ferroptosis resistance in melanocytes in an autocrine manner and further stimulated keratinocytes to take up melanin to deepen skin color by upregulating the F2R-like trypsin receptor 1 (F2RL1). In vivo , the delivery of ML329, a micropthalmia-associated transcription factor (MITF) inhibitor, could suppress melanogenesis and alleviate keloid in human keloid-bearing nude mice. Meanwhile, ML329 decreased the iron content and restored the sensitivities of ferroptosis. Collectively, melanin-lowing strategies may appear as a potential new therapeutic target for keloid.
... Keloids are also more likely to develop in more physically active areas such as the shoulders and neck. Infected wounds have a higher risk of developing into keloids (Shaheen, 2017). ...
Article
Full-text available
Fibroblasts that produce excess collagen and growth factors play a role in the pathogenesis of keloid formation. In general, keloids are treated with intralesional corticosteroids alone or with a combination of other modalities, but the recurrence rate is still relatively high, so alternative treatments such as stem cells are being investigated, one of which is Mesenchymal Stem Cells (MSC), which have proven to be useful in healing keloids. Therefore, this literature review aims to discuss the effects of stem cell therapy in the treatment of keloids. In this literature review, 36 journals were used that discussed stem cell therapy in the treatment of keloids taken from various journal sources, namely Google Scholar, Pubmed, Medline, Ebsco, Hindawi, and Cochrane which were published within the last 10 years. According to the source, MSC is divided into 2 types, namely Adipose Mesenchymal Stem Cells (AMSC) and Bone Marrow Mesenchymal Stem Cells (BMMSC). In several studies, AMSC is known to reduce the expression of TGF-β1, COL-1, and COL-2 proteins, and has been shown to inhibit the proliferation of fibroblasts in keloid patients. Whereas in the BMMSC study that was applied with Hydroxybutyl chitosan (HBC) and Arg-Gly-Asp (RGD) hydrogels for 7 days, it was shown to significantly reduce nodular collagen fibers (p<0.05). Keloids occur due to excessive production of collagen and are influenced by various factors such as age, gender, skin color, and genetics. Stem cell therapy, such as MSC, has been proven in various studies to be an alternative treatment for keloids
... Keloids are also more likely to develop in more physically active areas such as the shoulders and neck. Infected wounds have a higher risk of developing into keloids (Shaheen, 2017). ...
Article
Full-text available
Fibroblasts that produce excess collagen and growth factors play a role in the pathogenesis of keloid formation. In general, keloids are treated with intralesional corticosteroids alone or with a combination of other modalities, but the recurrence rate is still relatively high, so alternative treatments such as stem cells are being investigated, one of which is Mesenchymal Stem Cells (MSC), which have proven to be useful in healing keloids. Therefore, this literature review aims to discuss the effects of stem cell therapy in the treatment of keloids. In this literature review, 36 journals were used that discussed stem cell therapy in the treatment of keloids taken from various journal sources, namely Google Scholar, Pubmed, Medline, Ebsco, Hindawi, and Cochrane which were published within the last 10 years. According to the source, MSC is divided into 2 types, namely Adipose Mesenchymal Stem Cells (AMSC) and Bone Marrow Mesenchymal Stem Cells (BMMSC). In several studies, AMSC is known to reduce the expression of TGF-β1, COL-1, and COL-2 proteins, and has been shown to inhibit the proliferation of fibroblasts in keloid patients. Whereas in the BMMSC study that was applied with Hydroxybutyl chitosan (HBC) and Arg-Gly-Asp (RGD) hydrogels for 7 days, it was shown to significantly reduce nodular collagen fibers (p<0.05). Keloids occur due to excessive production of collagen and are influenced by various factors such as age, gender, skin color, and genetics. Stem cell therapy, such as MSC, has been proven in various studies to be an alternative treatment for keloids
... Although African Americans, Asians, and Hispanics, those who have darker skin are more susceptible then the Caucasians are at a greater risk of developing keloid scar, otherwise there is no exception. People with highly-pigmented (melanin) skin can develop keloids 15 folds more than compared to white skin persons [7]. ...
Article
Full-text available
Abstract Keloid etiology is multifactorial. Earlier in our study we advocated that there is a delay in epitheliation and due to continued growth of connective tissue which is coming beyond the surface of the skin and then sealing of the wound takes place. This holds true even now but the mechanism behind this process is still ambiguous. In this review we have mentioned various possible etiological factors and their role in scar formation. Electron microscopic histological structures of both the types of keloids i e spontaneous and pathological are almost similar except their basement membrane which is somewhat irregular and not distinctly visible in spontaneous keloids [3], [4]. The transcription and translation of collagen I and III, fibronectin, laminin, periostin, and tenascin are all increased in raised dermal scar tissue. However, hyaluronic acid, dermatopontin and decorin are decreased, and the expression and localisation of fibrillin and elastin fibres in the dermis are altered compared with normal skin and scars. [5], [6]. Although African Americans, Asians, and Hispanics, those who have darker skin are more susceptible then the Caucasians are at a greater risk of developing keloid scar, otherwise there is no exception. People with highly-pigmented (melanin) skin can develop keloids 15 folds more than compared to white skin persons [7]. It is also observed that darker subjects in the same ethnic group are at more risk than the lighter skinned persons for developing keloids; however so far nobody has shown any correlation with melanin and keloids. In addition to melanin other risk factors are also associated with keloid formation: In Asians the scar consists of 'connective tissue' and gristle-like fibers; these constituents are concentrated below the epidermis in the skin in between the fibroblasts which hold them together until the wound is closed. Due to incomplete epithelization, the fibroblasts continue to multiply even after the wound is filled in. The genetics of keloid formation has rarely been documented and no serious experimental data is available, therefore it is not yet understood well. Unfortunately, so far, no reports are available on in vitro model. The mode of inheritance of keloids is not known. Most keloids occur sporadically, but some cases are familial. Piercing bumps tend to appear more quickly and do not grow in size, while keloids take time to form and can continue to grow over time. Background keloids are proliferative fibrous growths that result from an excessive tissue response to skin trauma.
Article
Background The Keloid is an elevated fibrous scar that may extend beyond the borders of the original wound. Object To compare between topical and intralesional mitomycin C in the treatment of auricular keloids. Patients and methods Prospective randomized study in which 40 patients with auricular keloids were included. The patients were divided into 2 groups, Group I included 32 patients who underwent topical mitomycin C application after the surgical removal of the auricular keloids, while Group II included 8 cases who underwent intra-lesional injection of mitomycin C after surgical removal of the auricular keloids. Results The two groups showed no significant difference regarding patient or lesion criteria (p > .05). VSS decreased significantly from 10.63 and 11.0 down to 1.38 and 3.0 after treatment in the topical and intra-lesional groups respectively (p < .001). However, greater improvement and satisfaction was detected in the topical group. Conclusion Both topical and intra-lesional mitomycin C injection are effective methods in managing auricular keloids. However, better VSS scores and patient satisfaction are reported with topical administration.
Article
Full-text available
Keloids and hypertrophic scars are caused by cutaneous injury and irritation, including trauma, insect bite, burn, surgery, vaccination, skin piercing, acne, folliculitis, chicken pox, and herpes zoster infection. Notably, superficial injuries that do not reach the reticular dermis never cause keloidal and hypertrophic scarring. This suggests that these pathological scars are due to injury to this skin layer and the subsequent aberrant wound healing therein. The latter is characterized by continuous and histologically localized inflammation. As a result, the reticular layer of keloids and hypertrophic scars contains inflammatory cells, increased numbers of fibroblasts, newly formed blood vessels, and collagen deposits. Moreover, proinflammatory factors, such as interleukin (IL)-1α, IL-1β, IL-6, and tumor necrosis factor-α are upregulated in keloid tissues, which suggests that, in patients with keloids, proinflammatory genes in the skin are sensitive to trauma. This may promote chronic inflammation, which in turn may cause the invasive growth of keloids. In addition, the upregulation of proinflammatory factors in pathological scars suggests that, rather than being skin tumors, keloids and hypertrophic scars are inflammatory disorders of skin, specifically inflammatory disorders of the reticular dermis. Various external and internal post-wounding stimuli may promote reticular inflammation. The nature of these stimuli most likely shapes the characteristics, quantity, and course of keloids and hypertrophic scars. Specifically, it is likely that the intensity, frequency, and duration of these stimuli determine how quickly the scars appear, the direction and speed of growth, and the intensity of symptoms. These proinflammatory stimuli include a variety of local, systemic, and genetic factors. These observations together suggest that the clinical differences between keloids and hypertrophic scars merely reflect differences in the intensity, frequency, and duration of the inflammation of the reticular dermis. At present, physicians cannot (or at least find it very difficult to) control systemic and genetic risk factors of keloids and hypertrophic scars. However, they can use a number of treatment modalities that all, interestingly, act by reducing inflammation. They include corticosteroid injection/tape/ointment, radiotherapy, cryotherapy, compression therapy, stabilization therapy, 5-fluorouracil (5-FU) therapy, and surgical methods that reduce skin tension.
Article
Full-text available
Background: Keloid is a benign fibrous growth, which presents in scar tissue of predisposed individuals. It is a result of irregular wound healing, but the exact mechanism is unknown. However, several factors may play a role in keloid formation. To date, there are no studies of keloids in Syria, and limited studies on Caucasians, so we have investigated the risk factors of keloids in Syrians (Caucasians), and this is the main objective of this study. Methods: Diagnosis of keloids was clinically made after an interview and physical examination. We did a histopathological study in case the physical examination was unclear. The following information was taken for each patient; sex, Blood groups (ABO\Rh), cause of scarring, anatomical sites, age of onset, number of injured sites (single\multiple) and family history. Results: We have studied the clinical characteristics of 259 patients with keloids,130 (50.2 %) females and 129 (49.8 %) males. There were 209 (80.7 %) patients with keloids in a single anatomical site compared to 50 (19.3 %) patients with 130 keloids in multiple anatomical sites, 253 (97.68 %) patients with keloids caused by a single cause for each patient compared to 6 (2.32 %) patients with keloids caused by two different causes for each patient. Keloids could follow any form of skin injury, but burn was the most common (28.68 %). Also, keloids could develop at any anatomical sites, but upper limb (20 %) followed by sternum (19.17 %) was the most common. Over half of the patients developed keloids in the 11-30 age range. 19.3 % (50/259) of patients had family history, 76 % (38/50) of them had keloids located in the same anatomical sites of relative, also, 66 % (33\50) of them had keloids caused by the same cause. The following information was found to be statistically significant; people with blood group A (p?=?0.01) compared with other blood groups, spontaneous keloids in patients with blood group A (p?=?0.01), acne in males (p?=?0.0008) compared to females, acne in someone who has a previous acne keloid (p?=?0.0002), burn in someone who has a previous burn keloid (p?=?0.029), family history, especially for spontaneous (p?=?0.005), presternal (p?=?0.039) and shoulder (p?=?0.008) keloids, people in second and third decades (p?=?0.02) (p?=?0.01) respectively. Conclusion: Age of onset, sex, cause of scarring, blood groups, anatomical site, presence of family history and the number of site (multiple\single) were significant in keloid formation in Syrians.
Article
Full-text available
Keloid disease is a fibroproliferative dermal tumor with an unknown etiology that occurs after a skin injury in genetically susceptible individuals. Increased familial aggregation, a higher prevalence in certain races, parallelism in identical twins, and alteration in gene expression all favor a remarkable genetic contribution to keloid pathology. It seems that the environment triggers the disease in genetically susceptible individuals. Several genes have been implicated in the etiology of keloid disease, but no single gene mutation has thus far been found to be responsible. Therefore, a combination of methods such as association, gene-gene interaction, epigenetics, linkage, gene expression, and protein analysis should be applied to determine keloid etiology.
Article
Résumé La cicatrice chéloïde est une pathologie de la cicatrisation cutanée. Il s’agit d’une prolifération fibreuse du derme liée à une accumulation de fibres de collagène secondaire à une plaie cutanée. Son aspect clinique et anatomo-pathologique est caractéristique bien qu’elle soit souvent confondue avec une cicatrice hypertrophique. Le principal mécanisme physiopathologique est un dérèglement de la synthèse et de la destruction du collagène lié à une hyperactivité du TGFβ. Dans cette première partie, sont expliquées les caractéristiques cliniques, épidémiologiques, physiopathologiques et histologiques des cicatrices chéloïdes.
Article
Keloids is a fibroproliferative disease. The incidence of keloids among Asians has not been thoroughly studied. The objective of this study is to determine the incidence of keloids in Taiwan, which mainly consists of ethnic Chinese. Furthermore, we want to determine the comorbidity rate of other fibrosis-related diseases among keloid patients. This study was based on the National Health Insurance Research Database, which contains the data of 1 million randomly selected patients. Multivariate logistic regression analyses were employed to estimate the relative odds of keloids as a function of fibrosis-related diseases. The annual keloid incidence rate in Taiwan was 0.15 % for the general population. With a 1.33 ratio, women outnumbered men. Women with uterine leiomyoma have a 2.25-fold greater risk of keloids, compared with women without leiomyoma. We concluded that keloid incidence in Taiwan is approximately 0.15 %. Women with leiomyoma have a greater risk of keloids, this implicates that both diseases share a common etiopathological pathway.
Article
Both hypertrophic scars and keloid scars are caused by abnormal wound healing, the key feature of which is excess collagen fiber secretion by fibroblasts. Many different factors could affect the process of hypertrophic scar and keloid formation, but most have not been identified to date. We assume that, during wound healing, melanocytes from the stratum basale contact or interact with fibroblasts from the dermal layers after the basal membrane is damaged, which in turn facilitates fibroblast proliferation and the secretion and deposition of collagen. This plays a significant role in the generation of hypertrophic scars and keloids.
Article
Keloids are benign, fibroproliferative growths that occur as a result of dermal injury in ~15% of the population. They are characterized by their extension beyond the confines of the original injury and often present with pain and pruritus. Additionally, these growths may result in cosmetic deformities and contribute to significant emotional distress. It is thought that keloids form as a result of aberrancies in the normal wound-healing process, which is complex and involves an elegant interplay between multiple cell types, cytokines, and proteins. The exact etiology is unknown, but significant research efforts have been made. These efforts have revealed that various cell types in keloids are either hyperresponsive and/or overproductive of various growth factors. Additionally, keloid cell types respond differently to mechanical strain than skin cells in patients who do not form keloids. This lack of understanding of keloid pathophysiology has left the care provider with a lack of a single definitive treatment strategy. Instead, a multitude of therapies exist ranging from surgery to injectables to lasers and any combination thereof. This purpose of this article is to highlight our current knowledge and emerging scientific understanding of keloid pathology and the current management strategies.
Article
Keloids tend to occur on highly mobile sites with high tension. This study was designed to determine whether body surface areas exposed to large strain during normal activities correlate with areas that show high rates of keloid generation after wounding. Eight adult Japanese volunteers were enrolled to study the skin stretching/contraction rates of nine different body sites. Skin stretching/contraction was measured by marking eight points on each region and measuring the change in location of the marked points after typical movements. The distribution of 1,500 keloids on 483 Japanese patients was mapped. The parietal region and anterior lower leg were associated with the least stretching/contraction, while the suprapubic region had the highest stretching/contraction rate. With regard to keloid distribution, there were 733 on the anterior chest region (48.9%) and 403 on the scapular regions (26.9%). No keloids were reported on the scalp or anterior lower leg. Because these sites are rarely subjected to skin stretching/contraction, it appears that mechanical force is an important trigger that drives keloid generation even in patients who are genetically predisposed to keloids. Thus, mechanotransduction studies are useful for developing clinical approaches that reduce the skin tension around wounds or scars for the prevention and treatment of not only keloids but also hypertrophic scars.